Search contract descriptions, companies and agencies.
ASPR-21-00574 -- BASE PERIOD FUND TO MBIO DIAGNOSTICS TO DEVELOP THEIR LIGHTDECK SARS-COV ULTRA-RAPID ANTIGEN TEST TO ACHIEVE EUA AND 510K CLEARANCE
Total Committed
$5.65M
Product or Service Description
Biomedical Advanced Development R&D
Total Potential Value
$5.65M
Contracting Agency
Effective Date
Feb. 3, 2021
Funding Department
OFFICE OF ACQ MGMT POLICY
Type
Firm fixed price
Solicitation Procedure
Simplified acquisition
Extent Competed
Not competed under sap
Reason
Sap Non Competition (Far 13)
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| MBIO DIAGNOSTICS, INC. | ASPR-21-00574 -- BASE PERIOD FUND TO MBIO DIAGNOSTICS TO DEVELOP THEIR LIGHTDECK SARS-COV ULTRA-RAPID ANTIGEN TEST TO ACHIEVE EUA AND 510K CLEARANCE | Jan. 27, 2021 | $5,654,478 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.